Neural Analytics Launches Latest Software Release for the Lucid System, Its Portable Brain Monitoring Information Platform

Prevail Drug Coated Balloon Catheter Launches in Europe

Prevail Drug coated balloon catheter is used during percutaneous coronary intervention procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease.

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

July 25, 2017

Neural Analytics Inc., a medical device company developing and commercializing technology to measure, diagnose and track brain health, today announced the latest system update for its next-generation ultrasound device, the Lucid M1 Transcranial Doppler Ultrasound System™ (Lucid System).

Neural Analytics notes the Lucid System is an FDA cleared fully portable, all-in-one ultrasound system designed for measuring and displaying cerebral blood flow velocities and monitoring of patients with brain disorders.

“The launch of our latest system update further demonstrates our commitment to continually enhance our technology to better meet the needs of healthcare professionals and their patients,” said Leo Petrossian, Chief Executive Officer of Neural Analytics. “This launch has the potential to optimize patient care by enabling clinicians to quickly access critical brain health information with the option to save and archive data from our platform across the entire hospital network.”

The Lucid System uses a type of ultrasound called Trans Cranial Doppler to assess the brain’s blood vessels from outside the body. This analysis is non-invasive, can be performed in the physician’s office and can help the physician diagnose brain disorders, potentially eliminating the need for additional, more invasive tests. Many significant brain disorders are caused by blood flow disruption. The Lucid System is a battery-operated medical grade tablet device designed to be moved easily throughout a medical facility in a range of settings that require the rapid assessment of blood flow in the brain to expedite treatment.



Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.